Apollo Hospitals Enterprise Ltd

Q3 FY26Healthcare Services

Apollo Hospitals Enterprise Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹8,693

Market cap₹1.3L Cr

P/E61.0

Updated23 Aug 2026

Read4 min read

The short version

Platform GMV growth guidance: Around 30-35% year-on-year for the full year FY '26, excluding IP/OP GMV. Platform GMV is expected to grow around 30% this financial year and about 30% next year excluding IP/OP contributions.

From Apollo Hospitals Enterprise Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Platform GMV growth guidance: Around 30-35% year-on-year for the full year FY '26, excluding IP/OP GMV.
Hospital business revenue growth: Existing hospitals expected to grow at 12-14%, with additional beds adding another 3-4%.
Pharmacy physical stores: Targeting ~600 new store additions per year, with same-store growth at about 16-18%, driven by private label and store refresh initiatives.
Digital business (online pharmacy): GMV growing at about 30%, with an expected trajectory of 20-22% annual growth to reach INR62 billion by Q4 FY '27.
Margin expansion: Existing hospital business expected to improve margins by at least 100 basis points next year despite INR150 crore losses from new units.
Overall volume growth focus: Targeting a mix of volume increase and case mix/pricing improvements to drive ARPP growth of ~5%.

Profitability & Margins

Platform GMV is expected to grow around 30% this financial year and about 30% next year excluding IP/OP contributions.
Hospital business aims for 12-14% revenue growth on existing hospitals with an additional 3-4% from new beds next year.
Hospital margins in the existing network can expand by at least 100 basis points next year despite INR150 crore losses from new units.
New hospitals operationalizing 50% of 1,500 beds next year; break-even on ~1,300 beds expected in 2 years.
Digital business (Apollo 24/7 and pharmacy) targeting about 25% growth over next five quarters, with online pharmacy showing 30%+ GMV growth.
EBITDA losses from new hospitals are expected but mitigated by improved asset utilization and cost control in existing network.
Overall margin expansion and revenue growth poised to maintain strong profitability trajectory over coming years.

See what Apollo Hospitals Enterprise Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

1,500 new hospital beds to be added over the next year, with 50% (750 beds) operationalized in the coming year and the remaining 750 beds thereafter.
Breakeven expected on 1,300 new beds within 2 years.
Operationalization phased: 40-50% of beds expected to be operationalized by Q1, including facilities in Calcutta, Hyderabad, Pune, Sarjapur; Gurugram beds expected by Q2 due to delays.
Capital investment focused on phased capacity operationalization and opening new beds in Healthcare Services.
Continued investments in clinical excellence, technology, and market share expansion.
No specific quantification of total capex provided but strategic focus on expansion and technology adoption to drive growth and profitability.

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Health X Platform₹955 Cr

Rev 1Mar 1

2Chandan Healthca₹496 Cr

Rev 1Mar 3

3₹65.8K Cr

Rev 2Mar 1

4₹658 Cr

Rev 2Mar 2

5₹97.2K Cr

Rev 2Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

There is no specific mention of any current or future fundraising through debt or equity in the provided transcript on page 18 or the surrounding pages.
The management discussed operational expansion, new beds, revenue growth, and margin guidance but did not indicate plans for raising capital through equity or debt.
The focus appears to be on phased capacity operationalization, improving profitability, and disciplined execution rather than fundraising activities.
Any material update on fundraising, if planned, might be communicated in future disclosures or earnings calls beyond the current transcript.

See what Apollo Hospitals Enterprise Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided transcript from the Apollo Hospitals Limited conference call does not contain explicit information regarding the company's current or expected order book or pending orders. The discussion primarily centers around operational aspects such as hospital bed capacity expansion, occupancy rates, margin trajectories, revenue growth, and digital business performance. There is no mention of order book status or pending contracts. If you require specifics on order book or pending orders, please provide additional sections or documents that may cover this information.

Apollo Hospitals Enterprise Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹6.6K Cr, net profit ₹551 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Apollo Hospitals's management said in earlier quarters

Others in Healthcare Services this season

Vijaya Diagnost. (Q3 FY26)
FY '27 capex of INR 100-120 crores planned, supporting network expansion (Page 5). Key concall takeaways from Vijaya Diagnost.'s Q3 FY26 earnings call — and…
Aster DM Quality (Q3 FY26)
Mature hospitals show steady revenue growth of 14%, hospitals 3-7 years old growing at 10%, and new assets under 3 years growing at 19%. Key concall takeaways…
Chandan Healthca (Q3 FY26)
The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…
Rainbow Child. (Q3 FY26)
Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…

Compare:vs Max Healthcare vs Manipal Health vs Fortis Health.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Apollo Hospitals Enterprise Ltd Q3 FY26 results?

What is Apollo Hospitals Enterprise Ltd share price analysis?

Apollo Hospitals Enterprise Ltd currently shows a neutral. The stock trades at a P/E of 61.0 with a market cap of ₹128,263 Cr. Investors should review the full earnings analysis for detailed insights.

Is Apollo Hospitals Enterprise Ltd planning capital expenditure?

1,500 new hospital beds to be added over the next year, with 50% (750 beds) operationalized in the coming year and the remaining 750 beds thereafter.

Keep Apollo Hospitals Enterprise Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.